4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-026446
Chief Executive Officer sold 7,800 shares at an average $33.54 ($261,582)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2019-04-25 | Sale | −3,600 | $33.57 | $120,852 | 308,537 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2019-04-25 | Sale | −300 | $33.99 | $10,197 | 308,237 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2019-04-26 | Sale | −3,900 | $33.47 | $130,533 | 304,337 | I |
| Open-market sales · 7,800 sh · avg $33.54 · $261,582 | |||||||
Loading xslF345X03/doc4.xml…